emcyt- estramustine phosphate sodium capsule
pfizer laboratories div pfizer inc - estramustine phosphate sodium (unii: 75f375mt2n) (estramustine - unii:35lt29625a) - estramustine phosphate 140 mg - emcyt capsules are indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate. emcyt capsules should not be used in patients with any of the following conditions:
estracyt capsule 140 mg
pfizer private limited - estramustine phosphate sodium eqv estramustine - capsule - 140 mg - estramustine phosphate sodium eqv estramustine 140 mg
estracyt 140mg capsules
pfizer ltd - estramustine sodium phosphate - oral capsule - 140mg
emcyt capsule
pfizer canada ulc - estramustine phosphate sodium - capsule - 140mg - estramustine phosphate sodium 140mg - antineoplastic agents
estracyt 140 mg hard caps.
pfizer sa-nv - estramustine sodium phosphate monohydrate 156,7 mg - eq. estramustine phosphate 140 mg - capsule, hard - 140 mg - estramustine disodium phosphate monohydrate 156.7 mg - estramustine
emcyt cap 140mg capsule
kabi pharmacia canada inc. - estramustine phosphate sodium - capsule - 140mg - estramustine phosphate sodium 140mg - antineoplastic agents
estracyt
pharmacia limited company trading as pharmacia - estramustine phosphate 140mg - capsule - 140 mg - active: estramustine phosphate 140mg
estracyt
pfizer pharmaceuticals israel ltd - estramustine phosphate 140 mg - capsules - estramustine - second line therapy in prostatic carcinoma in advanced stages.
estracyt capsules 156.7mg (エストラサイトカプセル156.7mg)
nippon shinyaku co., ltd. - estramustine phosphate sodium hydrate - white capsules (length:19.0mm, diameter:6.5mm)
estracyt capsule 140 milligram
pharmacia ireland - estramustine phosphate sodium - capsule - 140 milligram